These biotechnological processes contribute significantly to the personalization of cancer treatment. By understanding the unique genetic makeup of an individual's cancer, therapies can be tailored to target specific mutations. This leads to higher efficacy and fewer side effects compared to one-size-fits-all treatments. Additionally, early detection through biomarkers allows for treatment to begin at a stage where it is more likely to be successful.
